Free Trial
LON:POLB

Poolbeg Pharma (POLB) Share Price, News & Analysis

Poolbeg Pharma logo
GBX 2.40 -0.15 (-5.88%)
As of 05/23/2025 12:25 PM Eastern

About Poolbeg Pharma Stock (LON:POLB)

Key Stats

Today's Range
2.40
2.62
50-Day Range
2.40
3.40
52-Week Range
2.25
14.50
Volume
1.83 million shs
Average Volume
2.03 million shs
Market Capitalization
£12.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs. Poolbeg comprises a strong and growing portfolio of development assets.

Receive POLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Poolbeg Pharma and its competitors with MarketBeat's FREE daily newsletter.

POLB Stock News Headlines

$19 for a FULL YEAR of stock picks?!
Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.
Hookipa Pharma to acquire Poolbeg Pharma
Poolbeg Pharma’s POLB 001 Shows Promise in CRS Treatment
See More Headlines

POLB Stock Analysis - Frequently Asked Questions

Poolbeg Pharma's stock was trading at GBX 7.10 at the beginning of 2025. Since then, POLB shares have decreased by 66.2% and is now trading at GBX 2.40.
View the best growth stocks for 2025 here
.

Poolbeg Pharma PLC (LON:POLB) announced its earnings results on Tuesday, May, 20th. The company reported ($1.16) earnings per share (EPS) for the quarter.

Shares of POLB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Poolbeg Pharma investors own include EQTEC (EQT), Great Western Mining (GWMO), Power Metal Resources (POW), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), Alzamend Neuro (ALZN) and Alpine 4 (ALPP).

Company Calendar

Last Earnings
5/20/2025
Today
5/24/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:POLB
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-4,500,219,166.67
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 1.14 per share
Price / Cash Flow
2.11
Book Value
GBX 2,489.80 per share
Price / Book
0.00

Miscellaneous

Free Float
N/A
Market Cap
£12.34 million
Optionable
Not Optionable
Beta
2.11
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (LON:POLB) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners